BMC pregnancy and childbirth · 2020
Intraoperative coagulopathy during cesarean section as an unsuspected initial presentation of COVID-19: a case report.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kinsey Kelly Elizabeth, Ganz Eric, Khalil Susan, Brustman Lois
Аннотация
BACKGROUND: The world's understanding of COVID-19 continues to evolve as the scientific community discovers unique presentations of this disease. This case report depicts an unexpected intraoperative coagulopathy during a cesarean section in an otherwise asymptomatic patient who was later found to have COVID-19. This case suggests that there may be a higher risk for intrapartum bleeding in the pregnant, largely asymptomatic COVID-positive patient with more abnormal COVID laboratory values.
CASE: The case patient displayed D-Dimer elevations beyond what is typically observed among this hospital's COVID-positive peripartum population and displayed significantly more oozing than expected intraoperatively, despite normal prothrombin time, international normalized ratio, fibrinogen, and platelets.
CONCLUSION: There is little published evidence on the association between D-Dimer and coagulopathy among the pregnant population infected with SARS-CoV-2. This case report contributes to the growing body of evidence on the effects of COVID-19 in pregnancy. A clinical picture concerning for intraoperative coagulopathy may be associated with SARS-CoV-2 infection during cesarean sections, and abnormal COVID laboratory tests, particularly D-Dimer, may help identify the patients in which this presentation occurs.
CASE: The case patient displayed D-Dimer elevations beyond what is typically observed among this hospital's COVID-positive peripartum population and displayed significantly more oozing than expected intraoperatively, despite normal prothrombin time, international normalized ratio, fibrinogen, and platelets.
CONCLUSION: There is little published evidence on the association between D-Dimer and coagulopathy among the pregnant population infected with SARS-CoV-2. This case report contributes to the growing body of evidence on the effects of COVID-19 in pregnancy. A clinical picture concerning for intraoperative coagulopathy may be associated with SARS-CoV-2 infection during cesarean sections, and abnormal COVID laboratory tests, particularly D-Dimer, may help identify the patients in which this presentation occurs.
Предметные рубрики MeSH
AdultAntifibrinolytic AgentsBetacoronavirusBlood Coagulation DisordersBlood Loss, SurgicalBreech PresentationC-Reactive ProteinCOVID-19CauteryCesarean SectionCoronavirus InfectionsFemaleFibrin Fibrinogen Degradation ProductsFibrinogenHemostasis, SurgicalHumansInternational Normalized RatioMethylergonovineOligohydramniosOxytocicsOxytocinPandemicsPlatelet CountPneumonia, ViralPregnancyPregnancy Complications, HematologicPregnancy Complications, InfectiousProthrombin TimeSARS-CoV-2Tranexamic AcidUterine Inertia